Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.32
+1.76 (0.84%)
AAPL  273.88
+1.74 (0.64%)
AMD  211.44
-2.41 (-1.12%)
BAC  51.60
+1.19 (2.36%)
GOOG  312.24
+1.32 (0.42%)
META  653.03
+13.73 (2.15%)
MSFT  399.36
+10.36 (2.66%)
NVDA  196.99
+4.14 (2.14%)
ORCL  148.99
+2.85 (1.95%)
TSLA  415.93
+6.55 (1.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.